Boston Scientific official defends stents
93936
The concerns that have been raised about the safety of drug-eluting stents at a major cardiology conference shouldn't mean it's time to go back to older treatments, the chief medical and scientific officer of Natick medical technology company Boston Scientific Corp. said yesterday.
588272
Boston Scientific Corp. shipped millions of dollars worth of coronary stents in fall 1998 even after company officials learned that the medical devices had high failure rates and may not have met specifications approved by the Food and Drug Administration.
223465
GAITHERSBURG, Md. -- Drug-coated stents increase the risk of potentially fatal blood clots and heart attacks in some patients, but not enough to warrant limiting use of the devices, federal advisers said yesterday .
205492
The three recalls of Boston Scientific Corp. cardiac stents since July 2 affected many more units than the company has previously disclosed, raising concerns among stock analysts about future inventory levels.
139261
Boston Scientific Corp. said yesterday it has won back the market share that its flagship cardiac stent system held before three safety recalls reduced doctors&#39; orders of the product.
700160
Boston Scientific Corp. shipped millions of dollars worth of coronary stents in fall 1998 even after company officials learned that the medical devices had
737459
One of the nation's leading   cardiologists is calling for a sweeping study to evaluate the   risk of potentially fatal blood clots related to widely used   heart devices that treat blocked heart arteries.
541914
Patients who get the leading drug-coated stents to prop open coronary arteries rather than bare-metal stents run no higher risk of death, according to a new report by a multinational team of doctors.
535961
Drug-coated stents that prop open the arteries of about 3 million people in the U.S. don't increase the risk of heart attack or death when used as labeled but may put patients at risk for blood clots, health advisers said Thursday.
503330
The U.S. Food and Drug Administration expects to inspect Boston Scientific Corp.'s Galway, Ireland factory in the "near future" as part of its probe into the company's coronary stent recall, the Wall Street Journal said on Friday.
65643
Drug-releasing stents used widely to keep clogged heart arteries open may increase the risk of potentially dangerous blood clots, but there is no conclusive evidence that the devices boost the likelihood of having a heart attack or dying if used as recommended, an expert panel said yesterday.
269332
One of the nation's leading   cardiologists is calling for a sweeping study that evaluates   the risks of potentially fatal blood clots related to widely   used heart devices that treat blocked heart arteries.
91224
U.S. health officials said on   Thursday they will ask outside advisers later this year to   review recent studies suggesting drug-coated stents may raise   the risk of blood clots months after they are implanted.
459813
Time is running out for Boston Scientific to resolve what could be a multibillion-dollar liability resulting from its foray into the stent business.
132632
The Food and Drug Administration is unlikely to sanction Boston Scientific Corp. after reviewing its handling of safety recalls of its new cardiac stent system, an agency official said yesterday.
476762
GAITHERSBURG, Md. -- Federal advisers yesterday said that drug-coated stents, which have been implanted in millions, offer clear benefits to many patients but present higher clotting risks to others, suggesting they may be overused.
332843
NATICK, Mass. - Boston Scientific Corp. violated its agreement with an Israeli company and acted in &quot;bad faith&quot; when it set up a secret stent-making operation in Ireland, according to a federal judge who ordered the companies to reach a settlement.